Zonisamide to label warning letters due to side effects.

The KFDA instructed all physicians and pharmacists on Sept. 16 carefully to monitor the hypohidrosis and rise of body temperatures for the patients, especially children who were medicated with Zonisamide, an anti-epileptic agent, until they receive further notification from the KFDA.

The KFDA also explained the adverse reactions of Zonisamide and instructed consumers to discontinue its admi...